GlassScriptPhysician profile
Pranav M Patel
NPI 1447395561
$52,861.51
in general payments reported to CMS, 2019-2025
26 companies · $10K in 2025
The $10K reported for 2025 was more than what 89% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,926 · 2020: $8,537 · 2021: $8,608 · 2022: $7,259 · 2023: $6,522 · 2024: $6,560 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $7,254 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,777.37 |
| Travel and Lodging | $7,254.14 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16,498.13 | 2019-2025 | Lifevest |
| Medtronic, INC. | $13,723.65 | 2021-2025 | Resolute Onyx, Symplicity G3, Micra |
| Abbott Laboratories | $5,892.77 | 2019-2025 | Aveir, Assurity, Gallant |
| Medtronic Vascular, INC. | $5,681.97 | 2019-2020 | |
| Boston Scientific Corporation | $3,205.99 | 2019-2024 | Rotapro, Watchman |
| Abiomed | $2,115.80 | 2021-2025 | Impella |
| Cardiovascular Systems INC. | $1,718.16 | 2019-2022 | |
| Edwards Lifesciences Corporation | $1,140.67 | 2022-2025 | Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $991.13 | 2019-2024 | |
| Penumbra, INC. | $499.47 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $313.46 | 2019-2023 | Xarelto |
| Impulse Dynamics (USA) INC. | $177.62 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $173.03 | 2019-2024 | Farxiga |
| Pfizer INC. | $164.77 | 2022-2025 | |
| Amgen INC. | $138.72 | 2019-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $135.23 | 2019-2025 | Jardiance |
| Terumo Medical Corporation | $109.53 | 2022-2023 | Heartrail, Metacross Otw |
| Bardy Diagnostics, INC. | $30.00 | 2022 | |
| Philips North America LLC | $29.92 | 2023 | |
| Merck Sharp & Dohme LLC | $29.69 | 2025 | Verquvo |
| Lilly USA, LLC | $24.96 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $15.79 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $15.26 | 2019 | |
| Amarin Pharma, INC. | $13.34 | 2019 | |
| Irhythm Technologies, INC. | $12.62 | 2022 | |
| Organogenesis INC. | $9.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pranav Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.